• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IBS 中的异常免疫调节和低度炎症:一刀切合适吗?

Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all?

机构信息

Laboratorio de Hígado, Páncreas y Motilidad (HIPAM), Department of Experimental, Medicine-Faculty of Medicine, Universidad Nacional Autónoma de México, Hospital General de México, Mexico, Mexico.

出版信息

Am J Gastroenterol. 2012 Feb;107(2):273-5. doi: 10.1038/ajg.2011.427.

DOI:10.1038/ajg.2011.427
PMID:22306945
Abstract

Evidences suggest that there is low-grade inflammation in the colonic mucosa and/or a state of immune activation in patients with irritable bowel syndrome (IBS). Results from available studies are inconsistent mainly because of differences in measures, methodologies and study populations. In this issue, Chang et al. evaluated a comprehensive set of cytokines, immune markers and immune-related cells in patients with non post infectious IBS (non PI-IBS) and controls. The main finding was a lower expression of the mRNA of the anti-inflammatory IL-10 cytokine in the colonic mucosa of women with non PI-IBS without any differences in the cell counts. These results suggest that in non PI-IBS, there is altered immune regulation/activation without evidence of low-grade mucosal inflammation. Further, PI and non PI-IBS may be associated with different alterations in immune function/activation.

摘要

有证据表明,在肠易激综合征(IBS)患者的结肠黏膜中存在低度炎症和/或免疫激活状态。由于测量方法、方法学和研究人群的差异,现有研究的结果并不一致。在本期杂志中,Chang 等人评估了一组非感染后肠易激综合征(非 PI-IBS)患者和对照组患者的细胞因子、免疫标志物和免疫相关细胞。主要发现是在非 PI-IBS 女性的结肠黏膜中抗炎细胞因子 IL-10 的 mRNA 表达较低,而细胞计数没有差异。这些结果表明,在非 PI-IBS 中,存在免疫调节/激活的改变,而没有低度黏膜炎症的证据。此外,PI 和非 PI-IBS 可能与免疫功能/激活的不同改变有关。

相似文献

1
Abnormal immune regulation and low-grade inflammation in IBS: does one size fit all?IBS 中的异常免疫调节和低度炎症:一刀切合适吗?
Am J Gastroenterol. 2012 Feb;107(2):273-5. doi: 10.1038/ajg.2011.427.
2
Serum and colonic mucosal immune markers in irritable bowel syndrome.肠易激综合征患者的血清和结肠黏膜免疫标志物。
Am J Gastroenterol. 2012 Feb;107(2):262-72. doi: 10.1038/ajg.2011.423. Epub 2011 Dec 13.
3
Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.感染后肠易激综合征患者肠道黏膜中辅助性 T 细胞 1/辅助性 T 细胞 2(Th1/Th2)细胞因子表达失衡。
BMC Gastroenterol. 2012 Jul 20;12:91. doi: 10.1186/1471-230X-12-91.
4
Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype.Toll 样受体在肠易激综合征中的作用:根据疾病亚型的不同,黏膜免疫激活存在差异。
PLoS One. 2012;7(8):e42777. doi: 10.1371/journal.pone.0042777. Epub 2012 Aug 17.
5
Peroxiredoxin 1 as an inflammatory marker in diarrhea-predominant and postinfectious irritable bowel syndrome.过氧化物酶 1 作为腹泻为主型和感染后肠易激综合征的炎症标志物。
Neurogastroenterol Motil. 2020 Feb;32(2):e13741. doi: 10.1111/nmo.13741. Epub 2019 Oct 15.
6
Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome.感染后肠易激综合征小鼠模型中细胞因子水平的变化
BMC Gastroenterol. 2015 Apr 1;15:43. doi: 10.1186/s12876-015-0272-8.
7
Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome.感染后肠易激综合征中肥大细胞的蛋白酶激活受体 4 状态。
Neurogastroenterol Motil. 2012 Feb;24(2):113-9, e82. doi: 10.1111/j.1365-2982.2011.01841.x. Epub 2011 Dec 11.
8
Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.粪便胆汁酸排泄正常或升高的肠易激综合征患者的结肠黏膜基因表达和基因型
Am J Physiol Gastrointest Liver Physiol. 2015 Jul 1;309(1):G10-20. doi: 10.1152/ajpgi.00080.2015. Epub 2015 Apr 30.
9
Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.静止期炎症性肠病中的功能性肠病症状:上皮屏障破坏和低水平炎症的作用。
Gut. 2014 May;63(5):744-52. doi: 10.1136/gutjnl-2012-304066. Epub 2013 Jul 22.
10
Irritable bowel syndrome: is the colonic mucosa to blame?肠易激综合征:结肠黏膜是否有问题?
Neurogastroenterol Motil. 2012 Dec;24(12):1051-3. doi: 10.1111/nmo.12039.

引用本文的文献

1
Increased Vδ1γδT cells predominantly contributed to IL-17 production in the development of adult human post-infectious irritable bowel syndrome.在成人感染后肠易激综合征的发展过程中,增加的 Vδ1γδT 细胞主要促进了 IL-17 的产生。
BMC Gastroenterol. 2021 Jun 30;21(1):271. doi: 10.1186/s12876-021-01722-8.
2
Improved Symptom Profiles and Minimal Inflammation in IBS-D Patients Undergoing a Long-Term Low-FODMAP Diet: A Lipidomic Perspective.IBS-D 患者长期低 FODMAP 饮食后症状谱改善且炎症轻微:从脂质组学角度看。
Nutrients. 2020 Jun 2;12(6):1652. doi: 10.3390/nu12061652.
3
Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.
肠易激综合征的发病机制、实验模型与现代药物治疗:关于脑-肠轴的故事
Curr Neuropharmacol. 2016;14(8):842-856. doi: 10.2174/1570159x14666160324144154.
4
Recent developments in the pathophysiology of irritable bowel syndrome.肠易激综合征病理生理学的最新进展
World J Gastroenterol. 2015 Jul 7;21(25):7621-36. doi: 10.3748/wjg.v21.i25.7621.
5
Impact of psychological stress on irritable bowel syndrome.心理压力对肠易激综合征的影响。
World J Gastroenterol. 2014 Oct 21;20(39):14126-31. doi: 10.3748/wjg.v20.i39.14126.
6
The malabsorption of commonly occurring mono and disaccharides: levels of investigation and differential diagnoses.常见单糖和双糖的吸收不良:研究水平与鉴别诊断
Dtsch Arztebl Int. 2013 Nov 15;110(46):775-82. doi: 10.3238/arztebl.2013.0775.
7
What role does wheat play in the symptoms of irritable bowel syndrome?小麦在肠易激综合征的症状中起什么作用?
Gastroenterol Hepatol (N Y). 2013 Feb;9(2):85-91.
8
Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.药物减少肠黏膜而非神经元 5-羟色胺可抵抗小鼠肠道炎症。
Gut. 2014 Jun;63(6):928-37. doi: 10.1136/gutjnl-2013-304901. Epub 2013 Jun 7.
9
Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome.肠易激综合征患者骨质疏松相关骨折风险增加。
Osteoporos Int. 2013 Apr;24(4):1169-75. doi: 10.1007/s00198-012-2141-4. Epub 2012 Sep 20.